CVS Health

CVS US Health Care Health Care Services
S&P 500
$94.66
-0.66%
Delayed · cached 15 min

Fair value analysis

CVS
CVS Health
Health Care›Health Care Services
$94.66
Close used for this calculation
$66.48Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
25/100
Profitability8/25
Returns3/25
Balance Sheet7/25
Efficiency7/25
Growth6/25
Weak
Quality radar
25Prof.8/25Ret.3/25Eff.7/25B.Sht7/25Growth6/25

Consensus fair value

$66.48
Above FV
▼ -29.8% against the close used
Model range $13.73 – $115.04
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear$13.73Fair value$66.48Bull$115.04
FairClose
52-week traded range
52W low $70.0852W high $110.60

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

CVS Health closed at $94.66, 42.4% above the consensus fair value of $66.48 drawn from 9 valuation models.

Financial DNA score 25/100 — Weak. P/E of 68.1x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
$115.04
+21.5%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
$43.99
-53.5%
√(22.5 × EPS × BVPS)
EPS=1.39, BVPS=61.87 · outside Graham range (P/E 68.1, P/B 1.5) — asset-light, treat as a rough floor
P/E Fair Value
$27.80
-70.6%
EPS × 20x (sector P/E)
EPS=1.39, Sector P/E=20x
Peter Lynch (PEG)
$13.82
-85.4%
EPS × Growth% (PEG = 1 is fair)
EPS=1.39, g=9.9%
EV/EBITDA
$72.85
-23.0%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=9.27B
Dividend Discount (DDM)
$33.91
-64.2%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=2.66, r=10%, g=2%
Book Value (P/B)
$13.73
-85.5%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=61.87, ROE=2.2%, g=3%, r=10%
Reverse DCF
$94.66
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 23.8% | Historical: -9.9%
Margin of Safety
$46.71
-50.7%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=62.28, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.